Literature DB >> 17128276

The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes.

Jianxun Song1, Shahram Salek-Ardakani, Takanori So, Michael Croft.   

Abstract

CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin (mTOR). Expression of aurora B in Cd28-/- T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28-/- T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17128276     DOI: 10.1038/ni1413

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  63 in total

1.  Inflammatory IL-15 is required for optimal memory T cell responses.

Authors:  Martin J Richer; Lecia L Pewe; Lisa S Hancox; Stacey M Hartwig; Steven M Varga; John T Harty
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

2.  USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance.

Authors:  Yu Zhang; Rong-Bei Liu; Qian Cao; Ke-Qi Fan; Ling-Jie Huang; Jian-Shuai Yu; Zheng-Jun Gao; Tao Huang; Jiang-Yan Zhong; Xin-Tao Mao; Fei Wang; Peng Xiao; Yuan Zhao; Xin-Hua Feng; Yi-Yuan Li; Jin Jin
Journal:  J Clin Invest       Date:  2019-05-28       Impact factor: 14.808

Review 3.  mTOR at the crossroads of T cell proliferation and tolerance.

Authors:  Anna Mondino; Daniel L Mueller
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

4.  Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1).

Authors:  Marianna Trakala; Gonzalo Fernández-Miranda; Ignacio Pérez de Castro; Christopher Heeschen; Marcos Malumbres
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

5.  Aurora kinase B/C inhibition impairs malignant glioma growth in vivo.

Authors:  Roberto Jose Diaz; Brian Golbourn; Maryam Shekarforoush; Christian A Smith; James T Rutka
Journal:  J Neurooncol       Date:  2012-03-01       Impact factor: 4.130

6.  Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.

Authors:  Fengyang Lei; Jianyong Song; Rizwanul Haque; Xiaofang Xiong; Deyu Fang; Yuzhang Wu; Susanne M A Lens; Michael Croft; Jianxun Song
Journal:  Eur J Immunol       Date:  2013-05-28       Impact factor: 5.532

7.  FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yuzhang Wu; Jianxun Song
Journal:  Arthritis Res Ther       Date:  2010-04-12       Impact factor: 5.156

8.  Targeting TOR dependence in cancer.

Authors:  Matthew R Janes; David A Fruman
Journal:  Oncotarget       Date:  2010-05

9.  A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.

Authors:  Boris Shor; Druie Cavender; Crafford Harris
Journal:  BMC Immunol       Date:  2009-05-20       Impact factor: 3.615

10.  Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps.

Authors:  Geng Xu; Jiahong Xia; Xiaoyang Hua; Han Zhou; Chuanzhao Yu; Zheng Liu; Kemin Cai; Jianbo Shi; Huabin Li
Journal:  Respir Res       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.